The global Erythropoietin Drugs market was valued at US$ 9157.8 million in 2023 and is anticipated to reach US$ 12990 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.

Erythropoietin Drugs Market

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with the peritubular capillary and proximal convoluted tubule.

The retail pharmacies segment dominated the erythropoietin drugs market and accounted for a major part of the overall market share. The ability of retail pharmacies to provide a large customer base for biosimilars coupled with the requirement from anemic patients for EPO drugs as a maintenance therapy is the key contributor to the dominance of this segment in the global market.

This report aims to provide a comprehensive presentation of the global market for Erythropoietin Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erythropoietin Drugs.

Report Scope

The Erythropoietin Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Erythropoietin Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Erythropoietin Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Erythropoietin Drugs Market Report

Report Metric	Details
Report Name	Erythropoietin Drugs Market
Accounted market size in 2023	US$ 9157.8 million
Forecasted market size in 2030	US$ 12990 million
CAGR	5.2%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Epoetin-alfa Darbepoetin-alfa Epoetin-beta Others
Segment by Application	Anemia Kidney Disorders Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Amgen, Johnson & Johnson, Roche, Galenica, Emcure, Kyowa Hakko Kirin, 3SBio, Biocon, LG Life Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Erythropoietin Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Erythropoietin Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Erythropoietin Drugs Market growing?

Ans: The Erythropoietin Drugs Market witnessing a CAGR of 5.2% during the forecast period 2024-2030.

What is the Erythropoietin Drugs Market size in 2030?

Ans: The Erythropoietin Drugs Market size in 2030 will be US$ 12990 million.

Who are the main players in the Erythropoietin Drugs Market report?

Ans: The main players in the Erythropoietin Drugs Market are Amgen, Johnson & Johnson, Roche, Galenica, Emcure, Kyowa Hakko Kirin, 3SBio, Biocon, LG Life Sciences

What are the Application segmentation covered in the Erythropoietin Drugs Market report?

Ans: The Applications covered in the Erythropoietin Drugs Market report are Anemia, Kidney Disorders, Other

What are the Type segmentation covered in the Erythropoietin Drugs Market report?

Ans: The Types covered in the Erythropoietin Drugs Market report are Epoetin-alfa, Darbepoetin-alfa, Epoetin-beta, Others

1 Erythropoietin Drugs Market Overview

1.1 Product Overview and Scope of Erythropoietin Drugs

1.2 Erythropoietin Drugs Segment by Type

1.2.1 Global Erythropoietin Drugs Market Value Comparison by Type (2024-2030)

1.2.2 Epoetin-alfa

1.2.3 Darbepoetin-alfa

1.2.4 Epoetin-beta

1.2.5 Others

1.3 Erythropoietin Drugs Segment by Application

1.3.1 Global Erythropoietin Drugs Market Value by Application: (2024-2030)

1.3.2 Anemia

1.3.3 Kidney Disorders

1.3.4 Other

1.4 Global Erythropoietin Drugs Market Size Estimates and Forecasts

1.4.1 Global Erythropoietin Drugs Revenue 2019-2030

1.4.2 Global Erythropoietin Drugs Sales 2019-2030

1.4.3 Global Erythropoietin Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Erythropoietin Drugs Market Competition by Manufacturers

2.1 Global Erythropoietin Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Erythropoietin Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Erythropoietin Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Erythropoietin Drugs Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Erythropoietin Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Erythropoietin Drugs, Product Type & Application

2.7 Erythropoietin Drugs Market Competitive Situation and Trends

2.7.1 Erythropoietin Drugs Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Erythropoietin Drugs Players Market Share by Revenue

2.7.3 Global Erythropoietin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Erythropoietin Drugs Retrospective Market Scenario by Region

3.1 Global Erythropoietin Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Erythropoietin Drugs Global Erythropoietin Drugs Sales by Region: 2019-2030

3.2.1 Global Erythropoietin Drugs Sales by Region: 2019-2024

3.2.2 Global Erythropoietin Drugs Sales by Region: 2025-2030

3.3 Global Erythropoietin Drugs Global Erythropoietin Drugs Revenue by Region: 2019-2030

3.3.1 Global Erythropoietin Drugs Revenue by Region: 2019-2024

3.3.2 Global Erythropoietin Drugs Revenue by Region: 2025-2030

3.4 North America Erythropoietin Drugs Market Facts & Figures by Country

3.4.1 North America Erythropoietin Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Erythropoietin Drugs Sales by Country (2019-2030)

3.4.3 North America Erythropoietin Drugs Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Erythropoietin Drugs Market Facts & Figures by Country

3.5.1 Europe Erythropoietin Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Erythropoietin Drugs Sales by Country (2019-2030)

3.5.3 Europe Erythropoietin Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Erythropoietin Drugs Market Facts & Figures by Country

3.6.1 Asia Pacific Erythropoietin Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Erythropoietin Drugs Sales by Country (2019-2030)

3.6.3 Asia Pacific Erythropoietin Drugs Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Erythropoietin Drugs Market Facts & Figures by Country

3.7.1 Latin America Erythropoietin Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Erythropoietin Drugs Sales by Country (2019-2030)

3.7.3 Latin America Erythropoietin Drugs Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Erythropoietin Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Erythropoietin Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Erythropoietin Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Erythropoietin Drugs Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Erythropoietin Drugs Sales by Type (2019-2030)

4.1.1 Global Erythropoietin Drugs Sales by Type (2019-2024)

4.1.2 Global Erythropoietin Drugs Sales by Type (2025-2030)

4.1.3 Global Erythropoietin Drugs Sales Market Share by Type (2019-2030)

4.2 Global Erythropoietin Drugs Revenue by Type (2019-2030)

4.2.1 Global Erythropoietin Drugs Revenue by Type (2019-2024)

4.2.2 Global Erythropoietin Drugs Revenue by Type (2025-2030)

4.2.3 Global Erythropoietin Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Erythropoietin Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Erythropoietin Drugs Sales by Application (2019-2030)

5.1.1 Global Erythropoietin Drugs Sales by Application (2019-2024)

5.1.2 Global Erythropoietin Drugs Sales by Application (2025-2030)

5.1.3 Global Erythropoietin Drugs Sales Market Share by Application (2019-2030)

5.2 Global Erythropoietin Drugs Revenue by Application (2019-2030)

5.2.1 Global Erythropoietin Drugs Revenue by Application (2019-2024)

5.2.2 Global Erythropoietin Drugs Revenue by Application (2025-2030)

5.2.3 Global Erythropoietin Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Erythropoietin Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Amgen

6.1.1 Amgen Corporation Information

6.1.2 Amgen Description and Business Overview

6.1.3 Amgen Erythropoietin Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Amgen Erythropoietin Drugs Product Portfolio

6.1.5 Amgen Recent Developments/Updates

6.2 Johnson & Johnson

6.2.1 Johnson & Johnson Corporation Information

6.2.2 Johnson & Johnson Description and Business Overview

6.2.3 Johnson & Johnson Erythropoietin Drugs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Johnson & Johnson Erythropoietin Drugs Product Portfolio

6.2.5 Johnson & Johnson Recent Developments/Updates

6.3 Roche

6.3.1 Roche Corporation Information

6.3.2 Roche Description and Business Overview

6.3.3 Roche Erythropoietin Drugs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Roche Erythropoietin Drugs Product Portfolio

6.3.5 Roche Recent Developments/Updates

6.4 Galenica

6.4.1 Galenica Corporation Information

6.4.2 Galenica Description and Business Overview

6.4.3 Galenica Erythropoietin Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Galenica Erythropoietin Drugs Product Portfolio

6.4.5 Galenica Recent Developments/Updates

6.5 Emcure

6.5.1 Emcure Corporation Information

6.5.2 Emcure Description and Business Overview

6.5.3 Emcure Erythropoietin Drugs Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Emcure Erythropoietin Drugs Product Portfolio

6.5.5 Emcure Recent Developments/Updates

6.6 Kyowa Hakko Kirin

6.6.1 Kyowa Hakko Kirin Corporation Information

6.6.2 Kyowa Hakko Kirin Description and Business Overview

6.6.3 Kyowa Hakko Kirin Erythropoietin Drugs Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Kyowa Hakko Kirin Erythropoietin Drugs Product Portfolio

6.6.5 Kyowa Hakko Kirin Recent Developments/Updates

6.7 3SBio

6.6.1 3SBio Corporation Information

6.6.2 3SBio Description and Business Overview

6.6.3 3SBio Erythropoietin Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 3SBio Erythropoietin Drugs Product Portfolio

6.7.5 3SBio Recent Developments/Updates

6.8 Biocon

6.8.1 Biocon Corporation Information

6.8.2 Biocon Description and Business Overview

6.8.3 Biocon Erythropoietin Drugs Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Biocon Erythropoietin Drugs Product Portfolio

6.8.5 Biocon Recent Developments/Updates

6.9 LG Life Sciences

6.9.1 LG Life Sciences Corporation Information

6.9.2 LG Life Sciences Description and Business Overview

6.9.3 LG Life Sciences Erythropoietin Drugs Sales, Revenue and Gross Margin (2019-2024)

6.9.4 LG Life Sciences Erythropoietin Drugs Product Portfolio

6.9.5 LG Life Sciences Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Erythropoietin Drugs Industry Chain Analysis

7.2 Erythropoietin Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Erythropoietin Drugs Production Mode & Process

7.4 Erythropoietin Drugs Sales and Marketing

7.4.1 Erythropoietin Drugs Sales Channels

7.4.2 Erythropoietin Drugs Distributors

7.5 Erythropoietin Drugs Customers

8 Erythropoietin Drugs Market Dynamics

8.1 Erythropoietin Drugs Industry Trends

8.2 Erythropoietin Drugs Market Drivers

8.3 Erythropoietin Drugs Market Challenges

8.4 Erythropoietin Drugs Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Erythropoietin Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Erythropoietin Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Erythropoietin Drugs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Erythropoietin Drugs Sales (K Pcs) of Key Manufacturers (2019-2024)

Table 5. Global Erythropoietin Drugs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Erythropoietin Drugs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Erythropoietin Drugs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Erythropoietin Drugs Average Price (USD/Pcs) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Erythropoietin Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Erythropoietin Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Erythropoietin Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Erythropoietin Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Erythropoietin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erythropoietin Drugs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Erythropoietin Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Erythropoietin Drugs Sales by Region (2019-2024) & (K Pcs)

Table 18. Global Erythropoietin Drugs Sales Market Share by Region (2019-2024)

Table 19. Global Erythropoietin Drugs Sales by Region (2025-2030) & (K Pcs)

Table 20. Global Erythropoietin Drugs Sales Market Share by Region (2025-2030)

Table 21. Global Erythropoietin Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Erythropoietin Drugs Revenue Market Share by Region (2019-2024)

Table 23. Global Erythropoietin Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Erythropoietin Drugs Revenue Market Share by Region (2025-2030)

Table 25. North America Erythropoietin Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Erythropoietin Drugs Sales by Country (2019-2024) & (K Pcs)

Table 27. North America Erythropoietin Drugs Sales by Country (2025-2030) & (K Pcs)

Table 28. North America Erythropoietin Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Erythropoietin Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Erythropoietin Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Erythropoietin Drugs Sales by Country (2019-2024) & (K Pcs)

Table 32. Europe Erythropoietin Drugs Sales by Country (2025-2030) & (K Pcs)

Table 33. Europe Erythropoietin Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Erythropoietin Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Erythropoietin Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Erythropoietin Drugs Sales by Region (2019-2024) & (K Pcs)

Table 37. Asia Pacific Erythropoietin Drugs Sales by Region (2025-2030) & (K Pcs)

Table 38. Asia Pacific Erythropoietin Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Erythropoietin Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Erythropoietin Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Erythropoietin Drugs Sales by Country (2019-2024) & (K Pcs)

Table 42. Latin America Erythropoietin Drugs Sales by Country (2025-2030) & (K Pcs)

Table 43. Latin America Erythropoietin Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Erythropoietin Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Erythropoietin Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Erythropoietin Drugs Sales by Country (2019-2024) & (K Pcs)

Table 47. Middle East & Africa Erythropoietin Drugs Sales by Country (2025-2030) & (K Pcs)

Table 48. Middle East & Africa Erythropoietin Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Erythropoietin Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Erythropoietin Drugs Sales (K Pcs) by Type (2019-2024)

Table 51. Global Erythropoietin Drugs Sales (K Pcs) by Type (2025-2030)

Table 52. Global Erythropoietin Drugs Sales Market Share by Type (2019-2024)

Table 53. Global Erythropoietin Drugs Sales Market Share by Type (2025-2030)

Table 54. Global Erythropoietin Drugs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Erythropoietin Drugs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Erythropoietin Drugs Revenue Market Share by Type (2019-2024)

Table 57. Global Erythropoietin Drugs Revenue Market Share by Type (2025-2030)

Table 58. Global Erythropoietin Drugs Price (USD/Pcs) by Type (2019-2024)

Table 59. Global Erythropoietin Drugs Price (USD/Pcs) by Type (2025-2030)

Table 60. Global Erythropoietin Drugs Sales (K Pcs) by Application (2019-2024)

Table 61. Global Erythropoietin Drugs Sales (K Pcs) by Application (2025-2030)

Table 62. Global Erythropoietin Drugs Sales Market Share by Application (2019-2024)

Table 63. Global Erythropoietin Drugs Sales Market Share by Application (2025-2030)

Table 64. Global Erythropoietin Drugs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Erythropoietin Drugs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Erythropoietin Drugs Revenue Market Share by Application (2019-2024)

Table 67. Global Erythropoietin Drugs Revenue Market Share by Application (2025-2030)

Table 68. Global Erythropoietin Drugs Price (USD/Pcs) by Application (2019-2024)

Table 69. Global Erythropoietin Drugs Price (USD/Pcs) by Application (2025-2030)

Table 70. Amgen Corporation Information

Table 71. Amgen Description and Business Overview

Table 72. Amgen Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 73. Amgen Erythropoietin Drugs Product

Table 74. Amgen Recent Developments/Updates

Table 75. Johnson & Johnson Corporation Information

Table 76. Johnson & Johnson Description and Business Overview

Table 77. Johnson & Johnson Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 78. Johnson & Johnson Erythropoietin Drugs Product

Table 79. Johnson & Johnson Recent Developments/Updates

Table 80. Roche Corporation Information

Table 81. Roche Description and Business Overview

Table 82. Roche Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 83. Roche Erythropoietin Drugs Product

Table 84. Roche Recent Developments/Updates

Table 85. Galenica Corporation Information

Table 86. Galenica Description and Business Overview

Table 87. Galenica Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 88. Galenica Erythropoietin Drugs Product

Table 89. Galenica Recent Developments/Updates

Table 90. Emcure Corporation Information

Table 91. Emcure Description and Business Overview

Table 92. Emcure Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 93. Emcure Erythropoietin Drugs Product

Table 94. Emcure Recent Developments/Updates

Table 95. Kyowa Hakko Kirin Corporation Information

Table 96. Kyowa Hakko Kirin Description and Business Overview

Table 97. Kyowa Hakko Kirin Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 98. Kyowa Hakko Kirin Erythropoietin Drugs Product

Table 99. Kyowa Hakko Kirin Recent Developments/Updates

Table 100. 3SBio Corporation Information

Table 101. 3SBio Description and Business Overview

Table 102. 3SBio Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 103. 3SBio Erythropoietin Drugs Product

Table 104. 3SBio Recent Developments/Updates

Table 105. Biocon Corporation Information

Table 106. Biocon Description and Business Overview

Table 107. Biocon Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 108. Biocon Erythropoietin Drugs Product

Table 109. Biocon Recent Developments/Updates

Table 110. LG Life Sciences Corporation Information

Table 111. LG Life Sciences Description and Business Overview

Table 112. LG Life Sciences Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 113. LG Life Sciences Erythropoietin Drugs Product

Table 114. LG Life Sciences Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Erythropoietin Drugs Distributors List

Table 118. Erythropoietin Drugs Customers List

Table 119. Erythropoietin Drugs Market Trends

Table 120. Erythropoietin Drugs Market Drivers

Table 121. Erythropoietin Drugs Market Challenges

Table 122. Erythropoietin Drugs Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Erythropoietin Drugs

Figure 2. Global Erythropoietin Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Erythropoietin Drugs Market Share by Type in 2023 & 2030

Figure 4. Epoetin-alfa Product Picture

Figure 5. Darbepoetin-alfa Product Picture

Figure 6. Epoetin-beta Product Picture

Figure 7. Others Product Picture

Figure 8. Global Erythropoietin Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Erythropoietin Drugs Market Share by Application in 2023 & 2030

Figure 10. Anemia

Figure 11. Kidney Disorders

Figure 12. Other

Figure 13. Global Erythropoietin Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Erythropoietin Drugs Market Size (2019-2030) & (US$ Million)

Figure 15. Global Erythropoietin Drugs Sales (2019-2030) & (K Pcs)

Figure 16. Global Erythropoietin Drugs Average Price (USD/Pcs) & (2019-2030)

Figure 17. Erythropoietin Drugs Report Years Considered

Figure 18. Erythropoietin Drugs Sales Share by Manufacturers in 2023

Figure 19. Global Erythropoietin Drugs Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Erythropoietin Drugs Players: Market Share by Revenue in 2023

Figure 21. Erythropoietin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Erythropoietin Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Erythropoietin Drugs Sales Market Share by Country (2019-2030)

Figure 24. North America Erythropoietin Drugs Revenue Market Share by Country (2019-2030)

Figure 25. U.S. Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Erythropoietin Drugs Sales Market Share by Country (2019-2030)

Figure 28. Europe Erythropoietin Drugs Revenue Market Share by Country (2019-2030)

Figure 29. Germany Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Erythropoietin Drugs Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Erythropoietin Drugs Revenue Market Share by Region (2019-2030)

Figure 36. China Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Taiwan Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Philippines Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America Erythropoietin Drugs Sales Market Share by Country (2019-2030)

Figure 47. Latin America Erythropoietin Drugs Revenue Market Share by Country (2019-2030)

Figure 48. Mexico Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Erythropoietin Drugs Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa Erythropoietin Drugs Revenue Market Share by Country (2019-2030)

Figure 53. Turkey Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. UAE Erythropoietin Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of Erythropoietin Drugs by Type (2019-2030)

Figure 57. Global Revenue Market Share of Erythropoietin Drugs by Type (2019-2030)

Figure 58. Global Erythropoietin Drugs Price (USD/Pcs) by Type (2019-2030)

Figure 59. Global Sales Market Share of Erythropoietin Drugs by Application (2019-2030)

Figure 60. Global Revenue Market Share of Erythropoietin Drugs by Application (2019-2030)

Figure 61. Global Erythropoietin Drugs Price (USD/Pcs) by Application (2019-2030)

Figure 62. Erythropoietin Drugs Value Chain

Figure 63. Erythropoietin Drugs Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions